Sodium Alginate in Chocolate Milk, Satiety and Glycemic Control
NCT ID: NCT01877460
Last Updated: 2013-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2012-01-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Isovolumetric and Isocaloric Preloads of Various Types of Milk on Food Intake, Subjective Appetite and Glycemic Response
NCT01025557
Comparing Liquid Versus Solid Forms of Sugars and Whey Protein
NCT01348685
The Effect of Dairy and Non-dairy Alternatives on Satiety and Post-meal Glycemia in Healthy Young Adults
NCT02491814
Functional and Value-Added Dairy Products and Blood Glucose Control
NCT05400694
The Effect of Milk Proteins on Satiety, Food Intake and Metabolic Control (Glycemia) in Early Adulthood
NCT02471092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sodium alginate-free chocolate milk
Sodium alginate-free chocolate milk (1% fat) (Beatrice Ltd., Toronto, Ontario)
Dietary intervention
All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.
1.25% sodium alginate chocolate milk
Chocolate milk (Beatrice Ltd., Toronto, Ontario) with 1.25% sodium alginate
Dietary intervention
All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.
2.5% sodium alginate chocolate milk
Chocolate milk (Beatrice Ltd., Toronto, Ontario) with 2.5% sodium alginate
Dietary intervention
All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.
2.5% sodium alginate milk-free water-based solution
Water solution with 2.5% sodium alginate
Dietary intervention
All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary intervention
All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-smoking male subjects,
* aged 20-30 years with a body mass index between 20 and 24.9 kg/m2, were recruited.
Exclusion Criteria
* smokers,
* dieters,
* individuals with lactose-intolerance or
* who are allergic to milk,
* individuals with gastrointestinal problems and
* individuals with diabetes or other metabolic diseases were excluded from the study.
20 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
G. Harvey Anderson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
G. Harvey Anderson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutritional Sciences, FitzGerald Building
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26942
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.